The new gold standard in biologic characterization – Develop your biologics faster and better with Prometheus

July 1, 2020

Development of therapeutic antibodies is a long and costly process. One key indicator of whether biologic candidates will be successful is stability. Prometheus enables rapid and precise characterization of conformational and colloidal stability of any protein using tiny amounts of sample, saving users precious time and resources while enabling a deeper biophysical understanding of their molecules. During this webinar, we will discuss how Prometheus is being used for candidate selection, engineering, and formulation.

Previous Article
Stability liabilities of biotherapeutic proteins: Early assessment as mitigation strategy
Stability liabilities of biotherapeutic proteins: Early assessment as mitigation strategy

Up next
Sizing accuracy and intra-assay precision of DLS measurements with Prometheus Panta
Sizing accuracy and intra-assay precision of DLS measurements with Prometheus Panta

Looking for the optimal formulation for your biologics candidates?

NanoTemper tools can help

Find out how